Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Zomedica's free cash flow for the twelve months ending Jun 30, 2026 was -$13.67M. For fiscal 2025 it was -$18.22M. The highest annual figure on record is -$4.79M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.22M | – |
| FY2024 | Dec 31, 2024 | -$28.84M | – |
| FY2023 | Dec 31, 2023 | -$27.31M | – |
| FY2022 | Dec 31, 2022 | -$12.46M | – |
| FY2021 | Dec 31, 2021 | -$14.42M | – |
| FY2020 | Dec 31, 2020 | -$16.25M | – |
| FY2019 | Dec 31, 2019 | -$15.79M | – |
| FY2018 | Dec 31, 2018 | -$11.78M | – |
| FY2017 | Dec 31, 2017 | -$7.26M | – |
| FY2016 | Dec 31, 2016 | -$4.79M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.64M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.32M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.01M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.70M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.58M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.87M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.23M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.11M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.55M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.77M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.70M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.66M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.65M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.35M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.84M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.86M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.72M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.99M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.11M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.71M | – |
See a number that looks wrong?